Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Characterization of methylthioadenosin phosphorylase (MTAP) expression in colorectal cancer
Yanmei Zhong1, Keliang Lu2, Suhua Zhu1
1a Department of Gastroenterology , Weifang Peoples' Hospital , Weifang , Shandong , China.
Purpose:
Tumour seriously affects people's quality of life. Colorectal cancer is a refractory tumour in digestive tract tumors. In colorectal cancer, gene expression abnormalities is the main reason for its incidence, we mainly focus on the molecular mechanism of MTAP in the development of colorectal cancer.
Methods:
The tumour tissue and its adjacent tissue samples of 50 patients with colorectal cancer were screened from July 2011 to February 2015, and the expression of MTAP was detected. Cell lines that overexpress MTAP and low expression of MTAP were constructed in colorectal cancer cell lines. The cell proliferation, invasion and migration was detected in the cells with different expression levels of MTAP. Immunohistochemistry was used to detect the expression of MTAP in liver metastasis and to investigate its clinical significance. And statistics of clinical significance.
Results:
Q-PCR results showed that the expression of MTAP in colorectal cancer cell lines were significantly higher than that normal human colonic myofibroblasts cell line. Cell proliferation test results showed that cell proliferation was accelerated when MTAP was overexpression, cell invasion and migration were simultaneously accelerated. The expression of MTAP in primary liver was positively correlated with metastatic disease in patients with liver metastatic colorectal cancer via EMT.
Conclusions:
MTAP accelerates the growth and metastasis of colorectal cancer through EMT.
Insights
Methylthioadenosine phosphorylase (MTAP) overexpression accelerates colorectal cancer growth and metastasis via epithelial-mesenchymal transition (EMT). This molecular mechanism is key to understanding colorectal cancer progression and developing targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Colorectal cancer (CRC) is a significant health concern with complex molecular underpinnings.
- Gene expression abnormalities play a crucial role in CRC development.
- Understanding the molecular mechanisms driving CRC is essential for effective treatment.
Purpose of the Study:
- To investigate the role of Methylthioadenosine phosphorylase (MTAP) in colorectal cancer development.
- To elucidate the molecular mechanism by which MTAP influences CRC progression.
- To explore the clinical significance of MTAP in colorectal cancer metastasis.
Main Methods:
- Analysis of MTAP expression in colorectal cancer tissues and adjacent normal tissues from 50 patients.
- Construction of colorectal cancer cell lines with varying MTAP expression levels (overexpression and low expression).
- Assessment of cell proliferation, invasion, and migration in response to MTAP levels.
- Immunohistochemical analysis of MTAP expression in liver metastases to determine clinical significance.
Main Results:
- MTAP expression was significantly higher in colorectal cancer cell lines compared to normal colonic myofibroblasts.
- MTAP overexpression accelerated cell proliferation, invasion, and migration.
- MTAP expression in primary tumors positively correlated with liver metastasis, suggesting a role in epithelial-mesenchymal transition (EMT).
Conclusions:
- MTAP promotes colorectal cancer growth and metastasis.
- The epithelial-mesenchymal transition (EMT) pathway is implicated in MTAP-driven colorectal cancer progression.
- MTAP represents a potential therapeutic target for colorectal cancer.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

